A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients

Dermatitis, Contact Clinical Trial

Official title:
Medrol® In Contact Dermatitis: A Prospective Study To Assess The Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Subjects

Status Completed

Clinical Trial Summary

This study will be a prospective, non-interventional, single arm and open label study, in patients with contact dermatitis requiring systemic steroid therapy with a purpose to obtain the real life effectiveness and tolerability of Medrol in treating contact dermatitis in Indian patients. Patients with contact dermatitis who have been prescribed for Medrol will be enrolled into the study and will be followed up for the resolution of symptoms

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00929981
Study type	Observational
Source	Pfizer
Contact
Status	Completed
Phase
Start date	September 2009
Completion date	September 2010

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT00779792` - Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation	Phase 4
Completed	`NCT00795951` - Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents	Phase 4
Recruiting	`NCT05492721` - Comparing Tissue Adhesives in Port Site Closure	Phase 3
Active, not recruiting	`NCT02614248` - The Use of Coconut Oil for the Prevention and Treatment of Diaper Dermatitis in the NICU Population	N/A
Completed	`NCT00612768` - Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations	Phase 2
Not yet recruiting	`NCT01011621` - Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis	Phase 3